Skip to content

COCIR @ RHFH

COCIR is the European trade association representing the medical imaging, radiotherapy, health ICT and electromedical industries. COCIR is unique as it brings together the healthcare, IT and telecommunications industries.

 

Digital Health Solutions: Is Europe Prepared to Take Up Innovation?

Tuesday 13th 15:30-17:00
Rainbow Stage (room 101AB)

From mobile health apps and wearables to telehealth and telemedicine, digital health solutions could sustainably support healthcare systems to become more citizen-centered and outcome-focused. Emerging technologies are breaking new paths to personalised care, but are Member States prepared to take them up? The new COCIR compendium entitled ‘Living Repository: Market Access Pathways for Digital Health Solutions’ assesses how Belgium, France, Germany, Spain, Sweden, and the United Kingdom integrate health innovation. Let’s exchange on national efforts to incorporate digital health solutions! 

Market Access of Medical Devices: From CE Mark through HTA to Coverage

Presentation: Where do we stand with Medical Devices in the European Union?

  • Alessia, Gramuglia, Senior Manager Technical and Regulatory Affairs, COCIR, Belgium

Presentation: HTA and Coverage in European health systems

  • Mattias Kyhlstedt, CEO of Synergus RWE AB, Sweden

Official release of the COCIR compendium: Living Repository: Market Access Pathways for Digital Health Solutions

  • Mattias Kyhlstedt, CEO of Synergus RWE AB, Sweden

Panel discussion: Coverage of Digital Health Solutions in the EU: Is Europe Ready to Take Up Innovation?

 

3 panellists compare statuses in Belgium, Finland and Germany:

  • Ulla Cahay, Head of Telemedicine, Institut national d’assurance maladie-invalidité, Belgium
  • Jari Haverinen, Senior Planning Officer in the Finnish Coordinating Center for Health Technology Assessment (FinCCHTA), Finland
  • Eugenia Rinaldi, research fellow at the Core Facility Digital Medicine and Interoperability of the Charité University Hospital, Germany

Chair and moderator:

  • Dr. Charles ALESSI, Chief Clinical Officer, éditohealth, United Kingdom